Valspark-1000 | Valacyclovir 1000 mg Tablets | Farlex Pharmaceuticals

Valspark-1000 Tablets

  • Home
  • Valspark-1000 Tablets
Valspark-1000 Tablets

Valspark-1000 Tablets

Composition : Valacyclovir Tablets 1000 mg

Packing : 10 x 1 x 10 Tablets

MRP : 11500/-

Enquire Now


Can't read the image? click here to refresh

Valspark-1000 Valacyclovir 1000 mg Tablets

Valspark-1000 is an oral antiviral tablet formulation containing Valacyclovir 1000 mg. Valacyclovir is an antiviral medicine used for the treatment and management of infections caused by herpes viruses.

Valacyclovir is converted in the body to acyclovir, which inhibits viral DNA replication. It is prescribed for specific herpes virus infections and should be used according to the diagnosis and treatment plan provided by a qualified healthcare professional.

Composition

Valacyclovir Tablets 1000 mg

Therapeutic Class

Antiviral

Uses of Valspark-1000

Valspark-1000 may be prescribed for:

• Treatment of herpes zoster (shingles) in appropriate adult patients
• Treatment of initial episodes of genital herpes
• Treatment of recurrent episodes of genital herpes
• Suppressive therapy for recurrent genital herpes when clinically appropriate
• Reduction of transmission of genital herpes as part of an appropriate treatment plan
• Treatment of herpes labialis (cold sores)
• Other clinically appropriate herpes virus infections as determined by a healthcare professional

How Valspark-1000 Works

Valacyclovir is converted to acyclovir in the body. Acyclovir interferes with viral DNA synthesis and inhibits the replication of susceptible herpes viruses.

Key Product Features

• Valacyclovir 1000 mg
• Oral tablet formulation
• Antiviral medicine
• Suitable for prescription-based treatment
• Used in the management of herpes virus infections
• 10 x 1 x 10 tablets packing

Product Information

Brand Name: Valspark-1000

Composition: Valacyclovir Tablets 1000 mg

Dosage Form: Tablets

Route of Administration: Oral

Therapeutic Class: Antiviral

Packing: 10 x 1 x 10 Tablets

Important Information

Valspark-1000 is a prescription medicine and should be used only under the supervision of a qualified healthcare professional.

Treatment should be started according to the diagnosis and timing recommended by the prescribing healthcare professional. The effectiveness of treatment can depend on how early therapy is initiated for certain herpes infections.

Patients with kidney problems may require dosage adjustment. Adequate hydration is important during treatment, particularly in patients who may be at increased risk of kidney-related adverse effects.

Patients should inform their doctor about existing kidney conditions, other medicines being taken and any history of significant drug reactions before starting treatment.

Valacyclovir may cause adverse effects such as headache, nausea, abdominal discomfort or other reactions. Serious neurological or renal reactions may occur in susceptible patients, particularly with inappropriate dosing or impaired kidney function.

Seek immediate medical attention if severe skin reactions, confusion, hallucinations, seizures, significant reduction in urination or other serious symptoms occur.

Dosage and Administration

The dosage and duration of treatment depend on the type of herpes infection, patient age, kidney function and clinical condition.

The medicine should be taken exactly as prescribed by the healthcare professional.

Do not self-medicate or change the prescribed dosage without medical advice.

Tablets should be swallowed with water and should be taken according to the prescribed schedule.

Storage

Store according to the conditions specified on the approved product label.

Keep the tablets in their original packaging.

Protect from excessive heat, moisture and direct light where applicable.

Keep out of reach of children.

Product Summary

Valspark-1000 contains Valacyclovir 1000 mg in an oral tablet formulation. It is an antiviral medicine used in the treatment and management of herpes virus infections, including herpes zoster and genital herpes, under appropriate medical supervision.